Intech Investment Management LLC Buys 51,496 Shares of Cigna Group $CI

Intech Investment Management LLC grew its stake in Cigna Group (NYSE:CI) by 242.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 72,724 shares of the health services provider’s stock after acquiring an additional 51,496 shares during the period. Intech Investment Management LLC’s holdings in Cigna Group were worth $20,963,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of CI. Massachusetts Financial Services Co. MA raised its position in Cigna Group by 1.1% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after purchasing an additional 123,479 shares during the last quarter. Dodge & Cox boosted its position in Cigna Group by 0.7% in the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after buying an additional 60,877 shares during the last quarter. Norges Bank acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $1,110,426,000. Arrowstreet Capital Limited Partnership raised its position in shares of Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after acquiring an additional 492,045 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Cigna Group by 0.7% during the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after acquiring an additional 15,014 shares during the period. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Up 1.2%

Shares of NYSE CI opened at $284.31 on Thursday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The stock has a market cap of $75.95 billion, a P/E ratio of 12.82, a P/E/G ratio of 0.97 and a beta of 0.27. The firm has a 50 day moving average price of $279.33 and a 200 day moving average price of $284.41.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period last year, the business posted $6.64 earnings per share. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CI. UBS Group reiterated a “buy” rating and issued a $375.00 price objective on shares of Cigna Group in a research report on Monday, February 9th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a research note on Tuesday, January 6th. Cantor Fitzgerald dropped their price target on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Royal Bank Of Canada reduced their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $330.63.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.